RHUMBLINE ADVISERS

Position in CRBP — Corbus Pharmaceuticals Holdings, Inc.

CIK 1115418 BOSTON, MA

Position in CRBP

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$191,942

+$187,417 QoQ

Shares Held

20,463

+4145.4% QoQ

Ownership

0.106%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#52

of 106 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 14% Shared 0% None 86%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. CRBP ranks #250 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	396,380	$196,893,837
2	REGN	Regeneron Pharmaceuticals, Inc.	157,794	$98,390,870
3	MRNA	Moderna, Inc.	809,853	$56,714,005
4	ALNY	Alnylam Pharmaceuticals, Inc.	165,579	$49,844,246
5	INCY	Incyte Corp	428,533	$48,578,500
6	RVMD	Revolution Medicines, Inc.	226,008	$42,326,778
7	ROIV	Roivant Sciences Ltd.	1,178,789	$41,717,342
8	JAZZ	Jazz Pharmaceuticals plc	163,018	$39,282,447

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$191,942	20,463	+4145.4%	Shares	Sole	2026-08-12
2026-03-31	$4,525	482	0.0%	Shares	Sole	2026-05-12
2025-12-31	$3,923	482	0.0%	Shares	Sole	2026-02-13
2025-09-30	$6,097	482	0.0%	Shares	Sole	2025-11-06
2025-06-30	$3,325	482	-96.8%	Shares	Sole	2025-08-12
2025-03-31	$80,388	15,139	+0.2%	Shares	Sole	2025-05-29
2024-12-31	$178,345	15,114	+2.9%	Shares	Sole	2025-05-29
2024-09-30	$303,075	14,691	+4.2%	Shares	Sole	2024-11-12
2024-06-30	$638,160	14,103	-86.0%	Shares	Sole	2024-08-01
2021-03-31	$198,761	100,894	-2.0%	Shares	Sole	2021-05-06
2020-12-31	$128,629	102,904	+15.7%	Shares	Sole	2021-02-10
2020-09-30	$160,045	88,914	-12.7%	Shares	Sole	2020-11-12
2020-06-30	$854,638	101,864	+24.3%	Shares	Sole	2020-08-13
2020-03-31	$429,528	81,971	—	Shares	Sole	2020-05-06
No filing history on record for this holder in this stock.